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Abstract
Objectives: Deproteinized	bovine	bone	mineral	(DBBM)	is	not	resorbable.	However,	
the	behavior	of	DBBM	under	 inflammatory	conditions	remains	unclear.	Aim	of	the	
study	was	therefore	to	evaluate	the	resorption	of	DBBM	under	local	inflammatory	
conditions	in	vivo	using	the	calvarial	osteolysis	model.
Methods: In	thirty	adult	BALB/c	mice,	DBBM	was	implanted	into	the	space	between	
the	elevated	soft	tissue	and	the	calvarial	bone.	Inflammation	was	induced	either	by	
lipopolysaccharides	 (LPS)	 injection	 or	 by	 polyethylene	 particles	 (Ceridust)	 mixed	
with	DBBM.	Three	modalities	were	randomly	applied	(n	=	10	each):	(a)	DBBM	alone	
(control),	 (b)	DBBM	+	LPS,	and	 (c)	DBBM	+	polyethylene	particles	 (Ceridust).	Mice	
were	euthanized	on	day	fourteen,	and	each	calvarium	was	subjected	to	histological	
and	µCT	analysis.	Primary	outcome	was	the	size	distribution	of	the	DBBM	particles.	
Secondary	outcome	was	the	surface	erosion	of	the	calvarial	bone.
Results: Histological	and	µCT	analysis	revealed	that	the	size	distribution	and	the	vol-
ume	of	DBBM	particles	in	the	augmented	site	were	similar	between	DBBM	alone	and	
the	combinations	with	LPS	or	polyethylene	particles.	Moreover,	histological	evalua-
tion	showed	no	signs	of	erosions	of	DBBM	particles	under	inflammatory	conditions.	
µCT	analysis	and	histology	further	revealed	that	LPS	and	the	polyethylene	particles,	
but	not	the	DBBM	alone,	caused	severe	erosions	of	the	calvarial	bone	as	indicated	
by	 large	voids	representing	the	massive	compensatory	new	immature	woven	bone	
formation	on	the	endosteal	surface.
Conclusions: Local	calvarial	bone	but	not	the	DBBM	particles	undergo	severe	resorp-
tion	and	subsequent	new	bone	formation	under	inflammatory	conditions	in	a	mouse	
model.
K E Y W O R D S
bone	regeneration,	bone	substitutes,	calvaria,	inflammation,	mice,	osteoclasts
s
o
u
r
c
e
:
 
ht
tp
s:
//
do
i.
or
g/
10
.7
89
2/
bo
ri
s.
13
77
85
 
| 
do
wn
lo
ad
ed
: 
27
.1
.2
02
0
2  |     KUCHLER Et aL.
1  | INTRODUC TION
Knowledge	of	bone	biology	in	conjunction	with	implant	placement	
has	 enormously	 increased	 in	 the	 last	 decades.	 However,	 surpris-
ingly	little	is	known	about	the	dynamics	of	bone	resorption.	Chronic	
inflammation,	 being	 a	 hallmark	 of	 peri‐implantitis	 (Berglundh,	
Gislason,	 Lekholm,	 Sennerby,	 &	 Lindhe,	 2004;	 Lindhe,	 Berglundh,	
Ericsson,	 Liljenberg,	 &	 Marinello,	 1992)	 and	 periodontitis	 (Page,	
Engel,	Narayanan,	&	Clagett,	1978),	cause	catabolic	changes	in	bone	
and	may	lead	to	implant	or	tooth	loss.	Thus,	we	have	solid	evidence	
about	the	destructive	impact	of	chronic	inflammation	on	the	resorp-
tion	of	alveolar	bone	in	peri‐implantitis	(Salvi,	Cosgarea,	&	Sculean,	
2017)	and	periodontitis	(Bartold	&	Van	Dyke,	2013).	Unexpectedly,	
however,	the	impact	of	chronic	inflammation	either	septic	or	aseptic	
on	 the	 resorption	 of	 bone	 substitutes,	 independent	 if	 they	 are	 of	
natural	 or	 synthetic	 origin,	 is	 sparse	 and	 almost	 exclusively	 based	
on	 histological	 observations	 (Scarano,	 Cholakis,	 &	 Piattelli,	 2017).	
The	question	then	arises	of	what	happens	to	the	bone	substitutes	
under	different	inflammatory	conditions?	This	lack	of	knowledge	is	
unexpected	because	inflammation	of	an	area	previously	augmented	
with	bone	substitutes,	for	example,	an	extraction	socket	(Kim	et	al.,	
2017),	is	rather	common.	Consequently,	there	is	a	clear	demand	to	
increase	 our	 knowledge	 on	 the	 performance	 of	 bone	 substitutes	
under	inflammatory	conditions.
Deproteinized	bovine	bone	mineral	(DBBM)	is	considered	a	slow	
resorbing	bone	substitute	that	 is	detectable	after	more	than	a	de-
cade	 in	biopsies	of	augmented	sites	 (Jensen,	Bosshardt,	Gruber,	&	
Buser,	2014).	Histology	allows	taking	a	detailed	observation	of	the	
multinucleated	cells	that	cover	a	part	of	the	DBBM	surface	(Jensen,	
Gruber,	Buser,	&	Bosshardt,	2015).	The	multinucleated	cells	express	
the	 tartrate‐resistant	acid	phosphatase	and	show	a	 ruffled	border	
with	cytoplasmic	extensions	toward	the	mineralized	surface	(Jensen	
et	al.,	2015).	What	cannot	be	observed,	however,	is	the	hallmark	of	
osteoclast	function,	Howship's	lacunae	(Chakar	et	al.,	2014).	This	is	
not	particularly	 surprising	because	biomaterials	behave	differently	
than	autografts,	also	when	osteoclasts	are	directly	seeded	on	DBBM	
(Perrotti,	 Nicholls,	 Horton,	 &	 Piattelli,	 2009;	 Taylor,	 Cuff,	 Leger,	
Morra,	&	Anderson,	2002).	These	in	vitro	studies	support	the	con-
cept	that	DBBM	is	resorbable,	at	least	to	a	minor	extent	as	compared	
to	a	bone	surface	under	the	same	experimental	conditions.	The	ex-
tent	to	which	DBBM	is	resorbable	under	chronic	inflammatory	con-
ditions	in	vivo	remains	unclear.
Our	 group	 discovered,	 using	 a	 minipig	 augmentation	 model,	
that	 when	 the	 occlusive	 protection	 of	 the	 augmented	 site	 is	 im-
paired,	severe	resorption	of	DBBM	is	initiated	(Busenlechner	et	al.,	
2012).	Osteoclasts	form	Howship's	lacunae	in	the	DBBM,	and	within	
12	weeks,	some	augmented	sites	were	almost	completely	resorbed	
(Busenlechner	et	al.,	2012).	Since	then,	the	findings	were	not	repro-
duced,	likely	because	bone	augmentation	usually	works	predictably	
in	vivo	and	clinicians	accept	 that	a	certain	percentage	of	bone	 re-
sorption	occurs.	Nevertheless,	 our	observations	have	 led	 to	 spec-
ulations	on	the	 impact	of	the	microenvironment	on	the	resorption	
of	DBBM	and	possibly	of	other	biomaterials.	There	is	a	hypothesis	
that	DBBM	placed	in	an	unstable	ectopic	soft	tissue	is	subjected	to	
resorption	(Busenlechner	et	al.,	2012;	Buser	et	al.,	2013).	To	gain	a	
better	understanding	of	the	underlying	cellular	and	molecular	mech-
anisms,	preclinical	models	were	introduced.
Calvarial	 bone	 of	 rodents	 became	 an	 established	 model	 to	
study	bone	resorption	induced	by	inflammation	in	vitro	and	in	vivo	
(Kassem	et	al.,	2015).	Severe	resorption	of	the	calvarial	bone	can	be	
induced	by	polyethylene	particles	(von	Knoch	et	al.,	2004;	Nich	et	
al.,	2010)	or	by	 lipopolysaccharides	 (LPS)	 injections	 (Kassem	et	al.,	
2015).	Osteoclastogenesis	is	rapidly	initiated,	and	the	resorption	of	
the	thin	cortex	of	the	calvarial	bone	can	be	measured	by	µCT	and	
histology.	The	concept	of	using	mouse	calvarial	bone	 for	augmen-
tation	is	not	entirely	new	(Ohba	et	al.,	2016),	but	we	are	the	first	to	
combine	it	with	the	calvarial	osteolysis	model	to	study	the	behavior	
of	bone	grafts,	 in	this	case	DBBM,	under	inflammatory	conditions.	
As	this	mouse	calvarial	model	enables	a	simple	access	for	both	the	
surgical	procedure	and	the	LPS	injection,	it	allows	to	verify	our	null	
hypothesis	that	DBBM	shows	no	signs	of	resorption	under	 inflam-
matory	conditions.	We	report	here	that	LPS	and	polyethylene	parti-
cles	cause	severe	catabolic	changes	in	the	calvarial	bone,	however,	
not	being	accompanied	by	substantial	alterations	of	the	size	distribu-
tion	of	the	DBBM	particles.
2  | MATERIAL AND METHODS
2.1 | Study design
The	Medical	University	 of	Vienna	 ethical	 review	board	 for	 animal	
research	approved	the	study	protocol	(GZ	BMWFW‐66.009/0193‐
WF/V/3b/2016‐2016).	 The	 study	 was	 performed	 in	 2017	 at	 the	
Department	 of	 Biomedical	 Research	 of	 the	 Medical	 University	
of	 Vienna	 in	 accordance	with	 the	ARRIVE	 guidelines.	 Thirty	male	
BALB/c	mice	(8–10	weeks,	20–25	g)	from	the	Division	for	Biomedical	
Research	 (Himberg,	 Austria)	 were	 randomly	 divided	 into	 three	
groups	with	10	animals	each	based	on	a	random	number	generator	
(GraphPad,	La	Jolla,	CA).	The	animals	were	treated	according	to	the	
guidelines	for	animal	care	with	free	access	to	water	and	a	standard	
diet	(Kilkenny,	Browne,	Cuthill,	Emerson,	&	Altman,	2010).
2.2 | Calvarial osteolysis model
UK	and	FJS	performed	the	surgeries.	All	animals	received	ketamine	
100	mg/kg	(AniMedica)	and	xylazine	hydrochloride	5	mg/kg	(Bayer	
Austria)	by	 intramuscular	 injection.	An	 incision	was	made	over	the	
calvaria.	 The	 periosteum	 was	 elevated	 off	 the	 external	 cortex	 of	
the	 calvarium	by	 sharp	dissection,	 and	 three	 treatment	modalities	
were	randomly	applied:	(a)	DBBM	alone	(50	mg,	Bio‐Oss,	Geistlich),	
(b)	DBBM	(25	mg)	together	with	polyethylene	particles	(25	mg;	1%;	
Ceridust	VP	3620;	Clariant),	and	(c)	alternatively,	in	the	third	group	
after	 the	DBBM	 (50	mg)	 augmentation	 inflammation	was	 induced	
by	two	local	injection	of	LPS	from	Escherichia coli	serotype	O55:	B5	
(25	mg/kg,	Sigma)	at	day	2	and	day	5	next	to	sagittal	suture	directly	
into	 the	 augmented	 area.	 The	 wounds	 were	 closed	 in	 two	 layers	
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with	resorbable	sutures	(Vicryl	6–0;	Ethicon	GmbH).	For	pain	relief,	
buprenorphine	0.06	mg/kg	 s.c.	 (Temgesic®,	 Temgesic,	 Reckitt	 and	
Colman	Pharm.)	and	piritramide	in	drinking	water	ad	lib	were	admin-
istered.	Mice	were	 euthanized	 on	 day	 fourteen	with	 an	 overdose	
of	sodium	pentobarbital	at	300	mg/kg	i.p.,	and	each	calvarium	was	
subjected	 to	 histological	 and	 micro‐computed	 tomographic	 (µCT)	
analysis.
2.3 | Micro‐CT analysis
After	euthanasia,	 the	heads	were	fixed	 in	phosphate‐buffered	for-
malin	 (Roti‐Histofix	4%,	Carl	Roth).	µCT	 scans	were	made	using	 a	
SCANCO	µCT	50	(SCANCO	Medical	AG)	at	90	kV/200	µA	with	an	
isotropic	resolution	of	17.2	µm	and	an	integration	time	of	500	ms.	
The	images	were	rotated	using	Amira	6.2	(Thermo	Fisher	Scientific)	
so	that	the	rostral	axis	lies	along	the	y‐axis	with	the	augmented	area	
oriented	toward	slice	0	in	the	approximate	center	of	the	image.	The	
images	were	then	registered	using	rigid	registration	so	that	the	cal-
varia	 are	 at	 the	 same	position	 and	orientation	 in	 all	 scans.	Region	
of	 interest	 (ROI)	was	defined	comprising	 the	augmented	compart-
ments	of	the	surgical	site	(Figure	1).	Using	the	Definiens	Developer	
XD2®	software	(Version	2.1.1),	the	ROIs	were	positioned	manually	
and	automatically	segmented	from	the	µCT	 images	with	a	specifi-
cally	developed	ruleset.	At	the	interior	surface	of	the	calvarial	bone,	
we	 determined	 the	 cortical	 porosity	 (void	 volume/tissue	 volume,	
Ct.Vd.V/TV	in	%),	cortical	bone	volume/tissue	volume	(Ct.BV/TV	in	
%),	and	cortical	thickness	(Ct.Th,	mm).	The	DBBM	particle	size	dis-
tribution	was	measured.	 In	addition,	 the	total	DBBM	graft	volume	
(mm3)	 and	 the	 relative	proportion	of	 soft	 tissue	 in	 the	augmented	
site	 (void	 volume/tissue	 volume,	 Vd.V/TV	 in	%)	were	 determined.	
Measurements	and	calculations	were	performed	with	the	Definiens	
Developer	XD2®	software	 (Version	2.1.1).	Calibration	and	blinding	
of	the	examiner	was	not	necessary	as	the	software	performed	the	
analysis	 automatically	 and	 identically	 for	 all	 samples.	 For	 further	
µCT	details	and	an	overview	on	the	scans,	see	Methods	and	Figure	
S1,	respectively.
2.4 | Histological analysis
All	samples	were	dehydrated	with	ascending	alcohol	grades	and	em-
bedded	in	 light‐curing	resin	(Technovit	7200	VLC	+	BPO;	Kulzer	&	
Co.).	Blocks	were	further	processed	using	Exakt	cutting	and	grinding	
equipment	(Exakt	Apparatebau).	Thin‐ground	sections	from	all	sam-
ples	were	prepared	according	to	Donath	(Donath	&	Rohrer,	2003),	in	
a	plane	parallel	to	the	sagittal	suture	and	through	the	center	of	the	
augmented	 area	 and	 stained	with	 Levai–Laczko	 dye.	 The	 slices	 of	
around	20	µm	were	scanned	using	an	Olympus	BX61VS	digital	vir-
tual	microscopy	system	(DotSlide	2.4,	Olympus)	with	a	20×	objective	
resulting	in	a	resolution	of	0.32	µm	per	pixel	and	then	evaluated.	An	
overview	of	the	augmented	site	is	depicted	in	Figure	1.
2.5 | Statistics
The	data	are	presented	graphically	using	 scatterplots,	overplotted	
by	the	mean	and	a	corresponding	bootstrap	95%	confidence	interval	
(CI).	 A	 non‐parametric	 approach	was	 used	 for	 inference:	 In	 a	 first	
step,	 an	 ANOVA‐type	 permutation	 test	 was	 calculated	 based	 on	
B	=	10000.	 In	case	of	significance,	pairwise	post	hoc	permutation	
tests	were	performed,	using	the	step‐down	maxT	procedure	to	ac-
count	 for	multiple	 testing	 (Hothorn,	 Bühlmann,	 Dudoit,	Molinaro,	
van	der	Laan,	2006,	Westfall	and	Troendle	2008).	All	computations	
were	done	using	R	version	3.5.1	(R	Core	Team,	2012).	Owing	to	the	
pilot	nature	of	the	study,	the	sample	size	was	chosen	based	on	ex-
perience	 from	previous	 studies	 (Ohba	 et	 al.,	 2016)	 to	 balance	 the	
ability	to	measure	significant	differences	while	reducing	the	number	
of	animals	used.
3  | RESULTS
3.1 | Catabolic changes of the mouse calvarial bone 
by LPS and Ceridust—µCT data
A	total	of	three	mice	were	lost	during	surgery,	and	as	a	result,	a	total	
of	27	mice	were	analyzed.	From	these	27	mice,	seven	showed	flap	
dehiscences;	three	mice	in	the	LPS	group,	two	mice	in	the	Ceridust	
group	and	two	mice	in	control	group	(DBBM	alone)	without	significant	
differences	between	the	groups	(p	=	.8011;	Table	S1).	µCT	analysis	
revealed	that	LPS	and	Ceridust	caused	catabolic	changes	in	the	form	
of	large	voids	of	the	calvarial	bone	(Figure	2).	The	large	voids	repre-
sent	the	massive	compensatory	new	immature	woven	bone	forma-
tion	on	the	endosteal	surface.	Quantitative	analysis	showed	that	in	
the	control	group	(DBBM	alone),	the	void	volume	in	the	cortical	bone	
was	5.2%	 (CI:	4.1–7.8).	 Injection	of	LPS	caused	an	almost	 fourfold	
increase	of	the	mean	void	volume	to	21.4%	(CI:	16.9–28.3,	p	<	.001).	
Ceridust	also	increased	the	mean	void	volume	around	twofold	over	
controls	to	14.2%	(CI:	11.2–16.6,	p	=	.062;	Figure	3a).	In	support	of	
these	observations,	there	was	an	indirect‐proportional	decrease	of	
F I G U R E  1  Deproteinized	bovine	bone	mineral	(DBBM)	
shows	no	signs	of	resorption	under	inflammatory	conditions.	
Representative	image	of	the	surgical	site	combining	µCT	and	
histology.	The	severe	erosions	of	the	calvarial	bone	are	visible	while	
the	morphology	of	the	DBBM	particles	is	not	obviously	disturbed
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cortical	bone	volume	(BV/TV)	from	81.5%	(CI:	80.1–83.3)	in	the	con-
trol	group	to	75.7%	(CI:	72.5–79.1,	p	=	 .006)	 in	the	LPS	group	and	
77.2%	(CI:	75.4–80.1,	p	=	 .062)	 in	the	Ceridust	group,	respectively	
(Figure	3b).	The	thickness	of	 the	cortical	bone	 (Figure	3c)	was	not	
significantly	changed	by	LPS	or	Ceridust	(p	=	.641).	Taken	together,	
LPS	and	Ceridust	caused	severe	erosion	of	the	frontal	calvarial	bone	
indicated	by	the	compensatory	increase	of	new	immature	bone.
3.2 | Catabolic changes of the mouse calvarial bone 
by LPS and Ceridust—histological data
Histological	observations	support	the	findings	from	the	μCT	analy-
sis.	As	indicated	in	Figure	4a,	the	control	group	showed	only	few	and	
small	resorption	sites	and	moderate	new	bone	formation	(Figure	4a).	
LPS	 and	 Ceridust	 caused	 extensive	 resorption	 as	 well	 as	 heavily	
compensatory	endocranial	bone	formation	underneath	the	cortical	
layer	 (Figure	 4b,c).	 Resorption	was	 strongest	 for	 Ceridust	 exhibit-
ing	more	and	 larger	resorption	sites	penetrating	the	cortical	bone.	
Resorption	often	affected	half	of	the	parietal	bone.	Compensatory	
bone	formation	resulted	in	a	loose	network	of	immature	woven	bone	
with	a	high	void	volume,	as	indicated	by	the	µCT	analysis.
3.3 | No changes of the DBBM particles by LPS and 
Ceridust—µCT
µCT	analysis	showed	a	relative	DBBM	volume	of	13.5%	(CI:	13.4–
15.2)	in	the	control	group.	No	significant	differences	in	DBBM	vol-
ume	were	observed	with	LPS	and	Ceridust	with	8.7%	(CI:	4.1–12.6)	
and	10.9%	(CI:	9.4–12.1),	respectively	(p	=	.057).	The	spaces	between	
the	DBBM	particles	or	void	volume/TV	in	the	augmented	site	were	
45.8%	 (CI:	 44.4–47.2)	 in	 the	 control	 group.	 Injection	 of	 LPS	 and	
the	use	of	Ceridust	caused	no	significant	changes	in	the	volume	of	
DBBM	G.V/TV	with	50.1%	(CI:	49.2–52.0)	and	51.9%	(CI:	50.9–52.8),	
respectively	(p	=	.092;	Figure	5a).	However,	there	is	at	least	a	trend	
that	inflammation	causes	looser	distribution	of	the	DBBM	particles	
in	the	augmented	site	compared	to	a	control	situation.	We	next	de-
termined	whether	LPS	and	Ceridust	changes	the	size	distribution	of	
the	DBBM	particles	in	the	augmented	site.	The	size	distribution	of	
the	DBBM	particles	ranged	from	0.001	mm3	to	more	than	0.1	mm3 
(Figure	 S2),	 but	 showed	 no	 significant	 differences	 when	 controls	
were	compared	to	LPS	and	Ceridust	groups	(Figure	6).
3.4 | No changes of the DBBM particles by LPS and 
Ceridust—histological analysis
Histology	supports	these	observations	as	there	was	no	obvious	in-
crease	in	the	presence	of	macrophages	or	osteoclast‐like	cells	caused	
by	LPS	and	Ceridust	on	the	surface	of	DBBM	(Figure	7).	In	all	treat-
ment	groups,	dehiscence	occurred,	yet,	DBBM	was	encased	between	
the	skin	of	the	scalp	and	the	bones	of	the	skull.	In	a	large	number	of	
cases	among	all	three	groups,	the	skin	overlying	the	bone	substitute	
material	showed	dehiscence	of	considerable	size.	Histological	signs	
F I G U R E  2  Lipopolysaccharides	(LPS)	and	Ceridust	induce	
calvarial	bone	resorption.	µCT	overview	of	the	augmentation	site.	
Periosteum	was	elevated,	and	the	calvarial	bone	was	augmented	
with	deproteinized	bovine	bone	mineral	(DBBM).	Inflammation	
was	induced	by	local	injection	of	lipopolysaccharides	(LPS)	
from	Escherichia coli	serotype	O55:	B5	or	Ceridust	polyethylene	
particles.	Note	the	severe	erosions	of	the	calvarial	bone	in	the	LPS	
and	Ceridust	group	while	only	a	few	signs	of	resorption	are	visible	
on	the	calvarial	bone	augmented	with	DBBM	alone
F I G U R E  3  Lipopolysaccharides	(LPS)	and	Ceridust	alter	the	cortical	porosity	and	cortical	bone	volume.	Based	on	µCT	data,	cortical	
porosity	(void	volume/tissue	volume,	Vd.V/TV	in	%),	cortical	bone	volume/tissue	volume	(Ct.BV/TV	in	%),	and	cortical	thickness	(Ct.Th	in	
mm)	were	determined.	Lipopolysaccharides	(LPS)	and	Ceridust	caused	an	increase	of	the	Vd.S/TS	with	p < .001 and p	=	.062,	respectively.	
LPS	and	Ceridust	decreased	cortical	bone	volume	(Ct.BV/TV)	with	p = .006 and p	=	.062,	respectively.	Thickness	of	the	cortical	bone	was	
not	different	between	the	three	groups	(p	=	.641).	The	data	are	presented	using	scatterplots	with	mean	and	a	corresponding	bootstrap	95%	
confidence	interval
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of	 inflammation	were	strongest	 in	 the	vicinity	of	 the	skin	defects.	
In	the	augmented	areas,	inflammatory	signs	were	weak	and	showed	
no	considerable	differences	between	the	groups.	The	size	of	DBBM	
particles	 seemed	 to	 be	 undiminished.	 Furthermore,	 particle	 size	
and	distribution	appeared	similar	in	all	treatment	groups	(Figure	7).	
Taken	 together,	 even	 though	DBBM	 treated	with	 LPS	or	Ceridust	
causes	 a	 resorption	of	 calvarial	 bone	 and	 a	 subsequent	 formation	
of	new	woven	bone,	no	obvious	changes	of	DBBM	itself	occurred	
between	the	treatment	groups.
4  | DISCUSSION
The	 results	 presented	 herein	 demonstrate	 that	 LPS	 and	 Ceridust	
cause	 a	 combination	of	 intense	 resorption	 and	 a	 following	 forma-
tional	activity	in	the	mouse	calvaria	bone.	The	size	distribution	and	
the	 overall	 volume	 of	DBBM	particles	were,	 however,	 unaffected	
by	LPS	and	Ceridust.	We	therefore	conclude	that	the	inflammatory	
response	to	LPS	and	Ceridust	that	causes	severe	resorption	of	the	
calvarial	bone	did	not	result	in	the	catabolic	changes	of	DBBM	parti-
cles.	This	observation	is	relevant	considering	that	it	provides	insight	
into	the	behaviour	of	DBBM	under	inflammatory	conditions.	The	oc-
currence	of	such	an	inflammatory	scenario	cannot	be	ruled	out	in	a	
clinical	setting,	for	example,	when	socket	preservation	in	a	patient	
affected	by	periodontitis	is	performed.
The	 severe	 catabolic	 changes	of	 calvarial	 bone	described	here	
upon	exposure	to	LPS	or	Ceridust	are	consistent	with	earlier	reports	
(Kassem	et	al.,	2015)	that	used	LPS	injections	or	polyethylene	par-
ticles.	However,	 in	these	earlier	studies,	LPS	from	P.	gingivalis	and	
the	TLR2	agonist	Pam2	were	injected	over	the	calvaria	without	aug-
mentation	for	only	6	days	and	no	analysis	of	bone	porosity	was	per-
formed	(Kassem	et	al.,	2015;	von	Knoch	et	al.,	2004).	We	have	used	
LPS	from	E. coli	serotype	O55:	B5	known	to	activate	TLR4	signaling,	
which	is	the	major	pathway	inflammatory	osteolysis	in	mouse	mod-
els	(Gruber,	2019).	We	have	modified	the	protocol	of	Nich	et	al.	(Nich	
et	al.,	2010)	who	distributed	20	µg	Ceridust	VP	3620	over	the	intact	
F I G U R E  4  Bone	resorption	induced	by	Lipopolysaccharides	(LPS)	and	Ceridust	induce	a	compensatory	repair.	Ground	sections	of	the	
augmented	area	stained	with	Levai–Laczko	dye.	The	high	magnification	shows	the	transition	of	the	calvarial	bone	and	the	DBBM	particles	
with	the	strong	signs	of	compensatory	repair	in	the	LPS	and	the	Ceridust	group	supporting	the	successful	initiation	of	inflammation.	This	
process	explains	the	significant	increase	Vd.S/TS	and	Ct.BV/TV	in	the	LPS	group.	No	signs	of	resorption	are	visible	on	the	surface	of	
deproteinized	bovine	bone	mineral	(DBBM)	particles
F I G U R E  5  No	changes	of	the	deproteinized	bovine	bone	mineral	(DBBM)	particles	by	lipopolysaccharides	(LPS)	and	Ceridust.	Based	
on	µCT	data,	different	regions	of	interest	(ROIs)	were	segmented.	We	determined	the	total	graft	volume	(G.V	in	mm3)	and	the	porosity	of	
the	augmented	area	(void	volume/tissue	volume,	Vd.V/TV	in	%).	The	data	are	presented	using	scatterplots	with	mean	and	a	corresponding	
bootstrap	95%	confidence	interval
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periosteum	using	a	sterile	sharp	surgical	spoon.	After	14	days	post-
operatively,	 quantitative	 µCT	 imaging	 revealed	 an	 approximately	
30%	change	of	osteolysis	that	is	based	on	TNF	signaling	(Merkel	et	
al.,	1999).	Therefore,	our	µCT	and	histological	data	support	previous	
observations	 that	 LPS	 and	 Ceridust	 can	 provoke	 inflammation‐in-
duced	changes	of	the	calvarial	bone.	This	is	the	first	study	to	show	
this	catabolic	response	in	the	presence	of	DBBM	in	a	mouse	calvarial	
augmentation	model.
In	 line	with	previous	 research,	we	 found	 sites	of	bone	 resorp-
tion	by	histological	analysis	that	correspond	to	the	sites	of	high	void	
volume	shown	in	the	µCT	analysis.	.LPS	and	Ceridust	triggered	the	
formation	and	activity	of	osteoclasts	 leading	to	the	erosion	of	 the	
bone	indicated	by	a	compensatory	woven	bone	formation	and	high	
void	volume.	Perhaps	more	important,	we	can	confirm	that	the	spec-
imens	with	a	high	void	volume	are	identical	with	those	showing	com-
pensatory	immature	woven	bone	in	the	histology.	Our	observation	
that	µCT	and	histology	are	congruent	is	a	solid	proof	that	the	auto-
mated	segmentation	used	for	the	structural	analysis	provided	valid	
information.	The	present	study	is	thus	not	only	new	with	respect	to	
the	preclinical	augmentation	and	inflammation	model,	but	also	be-
cause	we	present	 an	 innovative	 approach	 to	 quantitatively	 assess	
calvarial	osteolysis	with	ensuing	bone	formation	induced	by	LPS	and	
Ceridust.	We	therefore	provide	evidence	that	in	the	mouse	calvaria	
augmentation	model	DBBM	is	preserved	under	transient	inflamma-
tory	conditions.
An	 earlier	 study	 by	 our	 group	 suggested	 that	 DBBM	 is	 re-
sorbable	in	a	pig	calvaria	augmentation	model	under	as	yet	unex-
plained	conditions	(Busenlechner	et	al.,	2012).	It	is	possible	that	an	
inflammatory	 environment	 caused	 the	 underlying	molecular	 and	
cellular	mechanisms	 leading	 to	 resorption	 of	DBBM.	 Resorption	
of	DBBM	as	part	of	the	remodeling	process	was	earlier	suggested	
(Zitzmann,	 Scharer,	 Marinello,	 Schupbach,	 &	 Berglundh,	 2001).	
We	have	determined	the	DBBM	volume	and	also	analyzed	the	size	
distribution	 of	 all	 three	 groups	 of	 DBBM	 particles—the	 control,	
LPS,	and	Ceridust	group.	Independent	of	the	severe	inflammatory	
reaction,	we	 found	 no	 statistical	 changes	 in	 the	DBBM	 volume.	
Nevertheless,	there	was	a	trend	that	inflammation	causes	a	looser	
distribution	of	DBBM	particles	 in	 the	augmented	 site,	 likely	due	
to	 an	 edema	 and	 not	 osteoclast	 activity.	More	 relevant	 are	 our	
findings	 that	 the	 characteristic	 size	distribution	of	DBBM	 in	 the	
mouse	 calvaria	 with	 the	 majority	 of	 particles	 ranging	 between	
0.001 mm3	 to	more	than	0.1	mm3	was	not	considerably	changed	
F I G U R E  6  No	changes	in	the	particle	size	of	the	deproteinized	
bovine	bone	mineral	(DBBM)	by	lipopolysaccharides	(LPS)	and	
Ceridust.	Empirical	cumulative	probability	functions	for	particle	
size	(log	scale).	Statistical	analysis	showed	no	differences	in	the	size	
distribution	of	the	DBBM	particles	in	controls	compared	with	the	
LPS	and	Ceridust	group
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F I G U R E  7  Deproteinized	bovine	bone	mineral	(DBBM)	shows	no	signs	of	resorption	irrespective	of	inflammatory	condition.	The	high	
magnification	shows	the	DBBM	particles	in	controls	and	in	the	inflammatory	LPS	and	Ceridust	group.	No	signs	of	resorption	are	visible	on	
the	surface	of	DBBM	particles	independent	of	the	inflammation	induced,	by	LPS	or	Ceridust
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in	the	presence	of	LPS	and	Ceridust.	These	observations	together	
with	the	evidence	from	histology	suggest	that	DBBM	particles	are	
not	undergoing	resorption.
However,	 our	 mouse	 augmentation	 model	 has	 limitations	 as	
is	 does	 not	 represent	 long‐term	 chronic	 inflammation	 and	 also	
DBBM	 in	 the	 soft	 tissue	 of	 the	 oral	mucosa	may	 behave	 differ-
ently	than	in	the	calvaria	sites.	The	present	model	represents	an	
acute	and	a	 transient	 inflammation	 indicated	by	a	 compensation	
of	the	severe	osteolysis	through	an	increase	in	the	osteoblast	ac-
tivity	that	would	otherwise	be	suppressed	during	ongoing	inflam-
mation	(Diarra	et	al.,	2007).	Apart	from	the	clear	signs	of	former	
osteolysis	and	the	soft	tissue	dehiscence,	no	signs	of	an	ongoing	
inflammation	were	noticed.	 It	 can	be	 suggested	 that	 at	 the	 time	
of	 tissue	 harvesting,	 the	 inflammation	 had	 ceased	 and	 regen-
eration	 took	 over.	 This	 is	 also	why	 the	 number	 of	 inflammatory	
cells	could	not	be	quantified.	The	present	model	does	not	reflect	
the	 resorption	 pattern	 that	 has	 been	 observed	 using	 other	 ani-
mal	models	(Busenlechner	et	al.,	2012;	Gruber,	2019)	or	in	clinical	
situations	 of	 chronic	 inflammation	 and	 inflammatory	 osteolysis.	
Consequently,	the	effects	of	chronic	inflammation	on	DBBM	need	
to	be	further	evaluated.	Moreover,	wound	dehiscence,	as	was	seen	
in	all	groups,	 is	unpredictable	and	might	result	 in	 infection,	graft	
loss,	or	bone	resorption.	Since	it	was	observed	in	all	groups,	it	can-
not	be	attributed	to	the	higher	amount	of	calvarial	bone	erosion	in	
the	LPS	and	Ceridust	group.	Another	limitation	is	that	the	particles	
were	 stabilized	 only	 by	 the	 elevated	 periosteum;	 therefore,	 we	
cannot	 rule	out	 that	micro‐movements	might	have	displaced	 the	
biomaterial	 affecting	 the	 	 graft	 consolidation.	However,	 the	 pri-
mary	endpoint	was	related	to	the	possible	graft	resorption	under	
inflammatory	 conditions	 and	 in	 this	 sense	 the	histology	 support	
our	 findings.	 There	 is	 thus	 a	 demand	 to	 study	 the	 behaviour	 of	
DBBM	 in	 larger	 preclinical	 models	 under	 chronic	 inflammatory	
conditions.	
Taken	 together,	 the	 findings	 presented	 here	 support	 the	 idea	
that	short‐time	inflammation	per	se	 is	not	a	key	trigger	for	cellular	
degradation	or	resorption	of	DBBM	particles.
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